Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.

I, Moussa; MB, Leon; DS, Baim; WW, O'Neill; JJ, Popma; M, Buchbinder; J, Midwall; CA, Simonton; E, Keim; P, Wang; RE, Kuntz; JW, Moses

doi:10.1161/01.cir.0000129767.45513.71

Public

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.

Shared by NobleBlocks on May 3, 2004 • 12:00 AM UTC

Authors:

Moussa I

Leon MB

Baim DS

Abstract

Background Randomized clinical trials have shown that a sirolimus-eluting stent significantly reduces restenosis after percutaneous coronary revascularization. Diabetic patients are known to have a higher risk of restenosis compared with nondiabetic patients. The purpose of this analysis was to dete...

Discussions